This study systematically optimised the extraction process of Floccularia luteovirens polysaccharides (FLVP), establishing the optimal conditions as: power 400 W, temperature 52 °C, time 51 min, solid-liquid ratio 32:1 mL/g, and Ethylenediaminetetraacetic acid (EDTA) concentration 1.1 mg/mL. Three homogeneous polysaccharide fractions were isolated and purified: FLVP-I (124.327 kDa), FLVP-II (25.439 kDa), and FLVP-III (17.871 kDa). All three possess pyranose ring structures, with FLVP-I and FLVP-III containing both α- and β-glycosidic bonds, while FLVP-II exclusively contains α-glycosidic bonds. In antioxidant assays, FLVP-I exhibited the strongest activity, showing IC50 values of 0.27, 0.31, and 0.21 mg/mL against DPPH, ABTS+, and hydroxyl radicals, respectively, and restored the viability of H2O2-injured HepG2 cells to 87.42%. For hypoglycaemic activity, FLVP-II was most effective, with IC50 values of 0.29 and 0.22 mg/mL against α-amylase and α-glucosidase, respectively, and significantly promoted glucose consumption (8.02 mM) and hepatic glycogen synthesis (7.62 μg/mg protein) in insulin-resistant cells.
Feng et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: